Correction to: LncRNA PTAR promotes EMT and invasionmetastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression

Haihai Liang^#^{1

2}, Tong Yu^#^{1

2}, Yue Han^#³, Hua Jiang^{1

2}, Chengyu Wang³, Tianyi You³, Xiaoguang Zhao^{1

2}, Huitong Shan^{1

2}, Rui Yang^{1

2}, Lida Yang^{1

2}, Hongli Shan^{1

2}, Yunyan Gu^{4

5}

Affiliations

¹ Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
² Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, 150081, China.
³ Department of Systems Biology, College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150001, China.
⁴ Department of Systems Biology, College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150086, China. guyunyan@ems.hrbmu.edu.cn.
⁵ Training Center for Students Innovation and Entrepreneurship Education, Harbin Medical University, Harbin, 150086, China. guyunyan@ems.hrbmu.edu.cn.

^# Contributed equally.

PMID: 33836767
PMCID: PMC8034128
DOI: 10.1186/s12943-021-01344-4

Published Erratum

Correction to: LncRNA PTAR promotes EMT and invasionmetastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression

Haihai Liang et al. Mol Cancer. 2021.

. 2021 Apr 9;20(1):64.

doi: 10.1186/s12943-021-01344-4.

Authors

Affiliations

¹ Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
² Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, 150081, China.
³ Department of Systems Biology, College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150001, China.
⁴ Department of Systems Biology, College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150086, China. guyunyan@ems.hrbmu.edu.cn.
⁵ Training Center for Students Innovation and Entrepreneurship Education, Harbin Medical University, Harbin, 150086, China. guyunyan@ems.hrbmu.edu.cn.

^# Contributed equally.

PMID: 33836767
PMCID: PMC8034128
DOI: 10.1186/s12943-021-01344-4

No abstract available

PubMed Disclaimer

Figures

See this image and copyright information in PMC

Erratum for

LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.
Liang H, Yu T, Han Y, Jiang H, Wang C, You T, Zhao X, Shan H, Yang R, Yang L, Shan H, Gu Y. Liang H, et al. Mol Cancer. 2018 Aug 11;17(1):119. doi: 10.1186/s12943-018-0870-5. Mol Cancer. 2018. PMID: 30098599 Free PMC article.

References

1. Liang H, Yu T, Han Y, et al. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression. Mol Cancer. 2018;17:119. doi: 10.1186/s12943-018-0870-5. - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: LncRNA PTAR promotes EMT and invasionmetastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression

Affiliations

Correction to: LncRNA PTAR promotes EMT and invasionmetastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression

Authors

Affiliations

Figures

Erratum for

References

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources